Filter By Industry
Filter By Tag

Press Room

BioVision, Inc. Press releases

11 - 20 of 70 Press Releases

Aug 07, 2015
Ultrasensitive, Simple, HTP adaptable Kits for NOS activity and inhibitor screening.

Aug 06, 2015
Unique TEV Protease Activity and Inhibitor Screening Kits (Fluorometric)

Aug 05, 2015
Aprotinin is a commonly used protease inhibitor for trypsin and trypsin like enzymes. It has complex effects on many homeostatic functions including coagulation, platelet function and inflammation.

Jul 07, 2015
One step, quick, efficient procedure of conjugating FITC, Biotin, Cy3 or Cy5 to your choice of protein or antibody

Jun 30, 2015
Western blotting is a routinely used protocol for qualitative and quantitative detection/estimation of proteins. Western blot signals are in-part dependent on the developing substrate used.

Jun 25, 2015
Regulation of Hexokinase levels in the body is critical to maintain health. Hexokinase deficiency leads to severe human diseases such as X-linked muscular dystrophy and a rare autosomal recessive hemolytic anemia.

Jun 24, 2015
HIV-1 inhibitors’ research is at the forefront of active antiretroviral and cancer therapeutics.

May 18, 2015
With BioVision’s Highly Active EZCut™ TEV Protease – Cat # 7847

May 15, 2015
BioVision proudly announces the launch of a unique Cytochrome P450 reductase (CPR) activity assay kit which uses a synthetic colorimetric probe and a NADPH generating system.

Apr 01, 2015
BioVision scientists have developed a novel fluorescent glucose analog, which just like glucose, can be taken up by the cells through glucose transporters.

RSS Feed for BioVision, Inc. Press Releases